MedeAnalytics, a provider of healthcare analytics, has named Paul Kaiser as CEO. Previously, Kaiser worked at TriZetto Provider Solutions. MedeAnalytics is a portfolio company of Thoma Bravo.
EMERYVILLE, Calif., June 26, 2017 /PRNewswire/ — MedeAnalytics, a pioneer in healthcare analytics, today announced the appointment of Paul Kaiser as Chief Executive Officer.
Kaiser joins MedeAnalytics with more than a decade of experience working with payers and providers. His proven business acumen and extensive knowledge of the issues impacting the healthcare industry have enabled him to foster commendable organizational and team growth. Most recently as president of TriZetto Provider Solutions, Kaiser led teams to record setting sales and double digit revenue growth overseeing all aspects of the business including financial performance, business intelligence, sales and product management. Prior to joining TriZetto, Kaiser was the director of sales for Cerner Corporation’s managed services portfolio and directed the launch of Cerner’s global managed services solution. As an accomplished leader, Kaiser believes that creating a culture of integrity and trust through transparency and accountability leads to a productive, engaged workforce and more impactful customer outcomes.
“I am honored to join the team at MedeAnalytics,” said Paul Kaiser. “An understanding of cost, quality and operational insight is paramount during this transitional time in healthcare. MedeAnalytics’ sole focus has been and will continue to be to strengthen the business of healthcare in order to improve care. I look forward to working with our clients and teams to forward our mission.”
Kaiser replaces Andrew Hurd, who served the company as CEO for more than four years. Under Hurd’s leadership, MedeAnalytics experienced impressive and steady growth in annual bookings and now provides solutions to over 1,500 health plans and providers. Additionally, Hurd oversaw Thoma Bravo’s acquisition of a majority stake in MedeAnalytics in 2015, leveraging the private equity firm’s resources as a strategic partner to accelerate the company’s growth.
“Paul’s impressive knowledge of the healthcare marketplace and deep understanding of the problems our clients are trying to solve uniquely positions him to lead MedeAnalytics,” said David Weiss, Chairman, MedeAnalytics Board of Directors. “His expertise will allow him to bring the company to the next stage of growth in terms of scale and operational execution. He highly values teamwork and will continue MedeAnalytics’ stewardship with its customers and community.”
MedeAnalytics provides evidence-based insights to solve a real problem that plagues healthcare – how to use the immense amount of patient data collected along the care continuum to deliver cost-effective care and promote a healthier population. Its analytics platform delivers intelligence that helps healthcare organizations detect their greatest areas of risk and identify opportunities to improve their financial health. It empowers providers and health plans to collaborate and use data to strengthen their operations and improve the quality of care. MedeAnalytics’ cloud-based tools have been used to uncover business insights for over 1,500 healthcare organizations across the United States and United Kingdom. The company has also been named one of Modern Healthcare’s top 100 Best Places to Work in Healthcare for 2014, 2015 and 2016.
For more information, visit www.medeanalytics.com.